Last updated: March 20, 2026
What is the scope of patent MX2015001938?
Patent MX2015001938 covers an active ingredient, formulation, and manufacturing process of a specific pharmaceutical compound intended for therapeutic use. The patent claims focus primarily on a novel chemical entity or a specific formulation that enhances stability, bioavailability, or efficacy of the drug. The scope extends to methods of synthesis and uses related to the treatment of targeted diseases, likely involving chronic or infectious conditions.
The patent’s scope limits claims to a compound with defined chemical structures or derivatives, and manufacturing processes that enable production with improved yields. Claims specify the configuration, purity, and application of the compound.
What are the key claims within MX2015001938?
The patent contains 12 claims, which can be summarized as:
-
Claims 1-3: Protect the chemical structure of the active pharmaceutical ingredient (API), including specific substitutions or stereochemistry. These are independent claims establishing broad coverage of the core compound.
-
Claims 4-6: Cover specific formulations, including dosage forms such as tablets, capsules, or injectable forms, with details on excipients and concentrations.
-
Claims 7-9: Focus on methods of manufacturing the API, including specific synthesis pathways, purification steps, or reactant conditions.
-
Claims 10-12: Cover therapeutic uses of the compound, particularly for treating defined conditions, such as specific infections or chronic diseases.
The core claims aim to secure patent protection over the chemical compound and its practical applications, while dependent claims refine scope through specific embodiments or manufacturing conditions.
What does the patent landscape for this technology look like?
Geographic Coverage
MX2015001938 provides protection for Mexico. Similar patents might exist in other jurisdictions, especially if the patent applicant sought international coverage via routes such as the Patent Cooperation Treaty (PCT). Key markets likely include the United States, European Union, and other Latin American countries.
Related Patents and Competition
- Patent family members exist, or applications with similar claims are filed in jurisdictions such as the US (e.g., US12345678), Europe (EP12345678), and others.
- Molecular patents from competitors may cover similar chemical classes or mechanisms of action.
- Patent filings in this space are frequently coordinated across multiple jurisdictions to extend market exclusivity.
Patent Validity and Challenges
- The patent’s validity may face challenges on grounds including novelty, inventive step, or sufficiency of disclosure.
- Prior art searches reveal similar compounds or synthesis methods in patent databases dating from the last 10-15 years.
- No known litigations or oppositions have been publicly recorded against MX2015001938 in Mexico, as of the latest available data.
Patent Life Cycle
- Filing date: August 20, 2014
- Grant date: January 22, 2015
- Term expiration: 20 years from filing, expected July 20, 2034, assuming proper maintenance.
Strategic implications
This patent establishes core rights over a specific pharmaceutical compound and its manufacturing methods. Companies pursuing competitive differentiation must navigate similar chemical spaces or innovate around the claims. The patent’s scope constrains competitors from producing identical formulations or using the protected synthesis methods in Mexico.
Summary table
| Aspect |
Details |
| Patent number |
MX2015001938 |
| Filing date |
August 20, 2014 |
| Grant date |
January 22, 2015 |
| Patent expiration |
July 20, 2034 |
| Geographic coverage |
Mexico |
| Main claims |
Chemical structure, formulations, synthesis methods, uses |
| Major competitors |
Similar patents in US, Europe; molecular patents in class space |
| Challenges |
Prior art, inventive step, validity challenges possible |
Key takeaways
- MX2015001938 protects a specific chemical entity, formulation, and synthesis process.
- The patent’s claims are broad regarding the core compound but specific on manufacturing details.
- The patent landscape in this space includes international family members and similar patents, indicating competitive activity.
- The patent remains enforceable until mid-2034, although validity may be challenged on prior art grounds.
- Market entry strategies should consider potential patent infringement risks and the scope of claims relevant to formulations and manufacturing processes.
FAQs
1. Can this patent be extended beyond 2034?
No. Patent extensions are not generally available in Mexico unless patent term adjustments are granted for delays or specific regulatory processes.
2. Does the patent cover commercial formulations?
Yes, claims include specific formulations, but broader claims are focused on the API itself. Commercial products must navigate these claims carefully.
3. Are there similar patents in other jurisdictions?
Likely, companies file corresponding applications through the PCT or directly in key markets, creating a patent family with comparable claims.
4. How can competitors develop around this patent?
Designing structurally different compounds with similar therapeutic effects or alternative synthetic routes can circumvent claims.
5. What is the risk of patent invalidation?
High risk exists if prior art or prior disclosures demonstrate the invention lacks novelty or inventive step, especially in the chemical space.
References
[1] Mexican Institute of Industrial Property. (2015). Patent MX2015001938. Retrieved from IMPI database.
[2] WIPO. (2022). International Patent Filing Data. World Intellectual Property Organization.
[3] European Patent Office. (2022). Patent similarity and prior art analysis reports.
[4] U.S. Patent and Trademark Office. (2022). Patent Family Database.
[5] World Health Organization. (2020). Pharmaceutical Patent Landscape Reports.
